Navigation Links
Alere Inc. Schedules Conference Call for 10:00 a.m. ET July 28, 2010 to Discuss Second Quarter 2010 Results
Date:7/21/2010

WALTHAM, Mass., July 21 /PRNewswire-FirstCall/ -- Alere Inc. (formerly known as Inverness Medical Innovations, Inc.) (NYSE: ALR), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, today announced that it will release its second quarter 2010 earnings on Wednesday, July 28, 2010. The Company will also host a conference call beginning at 10:00 a.m. (Eastern Time) on that date to discuss these results and other corporate matters. During the conference call, the Company will discuss and answer questions concerning business and financial developments and trends. The Company's responses to questions, as well as other matters discussed during the conference call, may contain or constitute information that has not been disclosed previously.

The conference call may be accessed by dialing 706-679-1656 (domestic and international), an access code is not required, or via a link on the Alere website at www.alere.com/ic.  It is also available via link at http://event.meetingstream.com/r.htm?e=228683&s=1&k=0E445AC7F725CFFA3E6F855A0C7A7BFD.  An archive of the call will be available from the same link approximately two hours after the live call has concluded and will be accessible for 60 days.

By developing new capabilities in near-patient diagnosis, monitoring and health management, Alere enables individuals to take charge of improving their health and quality of life at home.  Alere's global leading products and services, as well as its new product development efforts, focus on infectious disease, cardiology, oncology, drugs of abuse and women's health.  Alere is headquartered in Waltham, Massachusetts.  

For additional information on Alere, please visit www.alere.com.  


'/>"/>
SOURCE Alere Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Inverness Medical Innovations Changes Name to Alere
2. MDS Patients on Five-Day Vidaza(R) Dosing Schedules Achieve Transfusion Independence Consistent with Seven-day Schedule
3. Wyeth Applauds Six Countries Across Europe, and the Middle East, That Recently Announced the Inclusion of the 7-Valent Pneumococcal Conjugate Vaccine (PCV7) in Their Immunization Schedules
4. Orexigen(R) Therapeutics Schedules July 20, 2009 Teleconference and Webcast Discussion of Contrave(R) Phase 3 Results
5. Orexigen(R) Therapeutics Schedules September 30, 2009 Teleconference and Webcast to Discuss Phase 2b Trial Results From Second Obesity Drug Candidate, Empatic(TM)
6. Misonix Schedules Fourth Quarter and Fiscal Year 2009 Financial Results Conference Call; October 1, 2009 at 4:30 p.m. Eastern
7. Schering-Plough Schedules Conference Call Webcast For 2009 Third Quarter Earnings
8. Mylan Schedules Third Quarter 2009 Financial Results Conference Call and Live Webcast
9. Volcano Corporation Schedules Third Quarter Conference Call, Webcast
10. VirtualScopics Schedules Third Quarter 2009 Earnings Announcement
11. Innophos Holdings, Inc. Schedules Call to Discuss Fourth Quarter and Full Year 2009 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... Dec. 6, 2016 The pen needles market ... from USD 1.65 billion in 2016, growing at a ... to 2021. Over the years, the pen needles ... cater to the growing demand for safety injections in ... development of safety pen needles with an aim to ...
(Date:12/6/2016)... , Dec. 6, 2016   AlloSource ... cartilage, cellular, bone, skin and soft-tissue allografts for ... , Business Process Manager, for being named to ... Baldrige National Quality Award by the Commerce Department,s ... the organization,s commitment to process excellence. The Baldrige ...
(Date:12/6/2016)... 6, 2016  Nearly 30 million people in ... epidemic of diabetes. 1 However, nearly 40% of ... levels (hyperglycemia) and significant glucose variability. 2 These patients ... cardiovascular events. If left untreated, hyperglycemia can lead to ... or blindness. 3 As part of ...
Breaking Medicine Technology:
(Date:12/6/2016)... (PRWEB) , ... December 06, 2016 , ... ... women at the Maine Women’s Magazine inaugural Maine Women’s Expo. Hundreds of women ... supporting an amazing local resource. The expo’s beneficiary this year was Crossroads, a ...
(Date:12/6/2016)... ... ... The Touchpoint Solution’s new neuroscience wearable, Buzzies, generated over $100K in sales ... than $25,000 on Kickstarter to bring to the market what people are ... and inventor, says she feels like she stumbled upon a miracle that she wants ...
(Date:12/6/2016)... ... December 06, 2016 , ... Why does the prevalence of obesity continue ... FRACP, includes a fresh look into the cause of obesity in his new book ... with the knowledge needed to lead a healthy life. Proietto said understanding the regulation ...
(Date:12/6/2016)... , ... December 06, 2016 , ... Of the variety ... ingredients in a hot dog. But contrary to common beliefs that hot dogs include ... the ingredients statement on the package. Ingredients combined with meat and poultry in a ...
(Date:12/6/2016)... ... December 06, 2016 , ... It can be argued that people these days ... members as they do for their human friends and family. As pets have ... highest quality and most innovative pet products has also increased. , For ...
Breaking Medicine News(10 mins):